244 related articles for article (PubMed ID: 35211843)
21. Gut Microbiota and Its Metabolite Deoxycholic Acid Contribute to Sucralose Consumption-Induced Nonalcoholic Fatty Liver Disease.
Shi Z; Chen G; Cao Z; Wu F; Lei H; Chen C; Song Y; Liu C; Li J; Zhou J; Lu Y; Zhang L
J Agric Food Chem; 2021 Apr; 69(13):3982-3991. PubMed ID: 33755449
[TBL] [Abstract][Full Text] [Related]
22. Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma.
Huang H; Ren Z; Gao X; Hu X; Zhou Y; Jiang J; Lu H; Yin S; Ji J; Zhou L; Zheng S
Genome Med; 2020 Nov; 12(1):102. PubMed ID: 33225985
[TBL] [Abstract][Full Text] [Related]
23. Gentamicin alleviates cholestatic liver injury by decreasing gut microbiota-associated bile salt hydrolase activity in rats.
Ma Y; Wang H; Yang J; Xin M; Wu X
Eur J Pharmacol; 2023 Jul; 951():175790. PubMed ID: 37179041
[TBL] [Abstract][Full Text] [Related]
24. Research on Gut Microbiota-Derived Secondary Bile Acids in Cancer Progression.
Yang R; Qian L
Integr Cancer Ther; 2022; 21():15347354221114100. PubMed ID: 35880833
[TBL] [Abstract][Full Text] [Related]
25. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome.
Yoshimoto S; Loo TM; Atarashi K; Kanda H; Sato S; Oyadomari S; Iwakura Y; Oshima K; Morita H; Hattori M; Honda K; Ishikawa Y; Hara E; Ohtani N
Nature; 2013 Jul; 499(7456):97-101. PubMed ID: 23803760
[TBL] [Abstract][Full Text] [Related]
26. Hepatocellular carcinoma: Novel understandings and therapeutic strategies based on bile acids (Review).
Luo W; Guo S; Zhou Y; Zhu J; Zhao J; Wang M; Sang L; Wang B; Chang B
Int J Oncol; 2022 Oct; 61(4):. PubMed ID: 35929515
[TBL] [Abstract][Full Text] [Related]
27. Simiao Wan modulates the gut microbiota and bile acid metabolism during improving type 2 diabetes mellitus in mice.
Chen Y; Zhu L; Hu W; Wang Y; Wen X; Yang J
Phytomedicine; 2022 Sep; 104():154264. PubMed ID: 35752076
[TBL] [Abstract][Full Text] [Related]
28. The deficiency of FKBP-5 inhibited hepatocellular progression by increasing the infiltration of distinct immune cells and inhibiting obesity-associated gut microbial metabolite.
Zhang C; Cui X; Feng L; Han Z; Peng D; Fu W; Xing Y
J Gastrointest Oncol; 2021 Apr; 12(2):711-721. PubMed ID: 34012660
[TBL] [Abstract][Full Text] [Related]
29. The gut microbiome-bile acid axis in hepatocarcinogenesis.
Wu L; Feng J; Li J; Yu Q; Ji J; Wu J; Dai W; Guo C
Biomed Pharmacother; 2021 Jan; 133():111036. PubMed ID: 33378947
[TBL] [Abstract][Full Text] [Related]
30. The gut bacterium
Streidl T; Karkossa I; Segura Muñoz RR; Eberl C; Zaufel A; Plagge J; Schmaltz R; Schubert K; Basic M; Schneider KM; Afify M; Trautwein C; Tolba R; Stecher B; Doden HL; Ridlon JM; Ecker J; Moustafa T; von Bergen M; Ramer-Tait AE; Clavel T
Gut Microbes; 2021; 13(1):1-21. PubMed ID: 33382950
[No Abstract] [Full Text] [Related]
31. Secondary bile acid-induced dysbiosis promotes intestinal carcinogenesis.
Cao H; Xu M; Dong W; Deng B; Wang S; Zhang Y; Wang S; Luo S; Wang W; Qi Y; Gao J; Cao X; Yan F; Wang B
Int J Cancer; 2017 Jun; 140(11):2545-2556. PubMed ID: 28187526
[TBL] [Abstract][Full Text] [Related]
32. Bile Salt Hydrolase Activity-Based Probes for Monitoring Gut Microbial Bile Acid Metabolism.
Han L; Xu R; Conwell AN; Takahashi S; Parasar B; Chang PV
Chembiochem; 2024 May; 25(10):e202300821. PubMed ID: 38564329
[TBL] [Abstract][Full Text] [Related]
33. Cholestasis impairs gut microbiota development and bile salt hydrolase activity in preterm neonates.
Lynch LE; Hair AB; Soni KG; Yang H; Gollins LA; Narvaez-Rivas M; Setchell KDR; Preidis GA
Gut Microbes; 2023; 15(1):2183690. PubMed ID: 36843227
[TBL] [Abstract][Full Text] [Related]
34. Alteration of serum bile acid profiles of HBV-related hepatocellular carcinoma identified by LC-MS/MS.
Dai S; Zhu J; Chen X; Zheng L; Li X; Liu L
J Cancer Res Clin Oncol; 2024 Mar; 150(3):157. PubMed ID: 38528272
[TBL] [Abstract][Full Text] [Related]
35. Gut microbiota derived bile acid metabolites maintain the homeostasis of gut and systemic immunity.
Su X; Gao Y; Yang R
Front Immunol; 2023; 14():1127743. PubMed ID: 37256134
[TBL] [Abstract][Full Text] [Related]
36. Bile Acid and Gut Microbiota in Irritable Bowel Syndrome.
Min YW; Rezaie A; Pimentel M
J Neurogastroenterol Motil; 2022 Oct; 28(4):549-561. PubMed ID: 36250362
[TBL] [Abstract][Full Text] [Related]
37. Prediagnostic alterations in circulating bile acid profiles in the development of hepatocellular carcinoma.
Stepien M; Lopez-Nogueroles M; Lahoz A; Kühn T; Perlemuter G; Voican C; Ciocan D; Boutron-Ruault MC; Jansen E; Viallon V; Leitzmann M; Tjønneland A; Severi G; Mancini FR; Dong C; Kaaks R; Fortner RT; Bergmann MM; Boeing H; Trichopoulou A; Karakatsani A; Peppa E; Palli D; Krogh V; Tumino R; Sacerdote C; Panico S; Bueno-de-Mesquita HB; Skeie G; Merino S; Ros RZ; Sánchez MJ; Amiano P; Huerta JM; Barricarte A; Sjöberg K; Ohlsson B; Nyström H; Werner M; Perez-Cornago A; Schmidt JA; Freisling H; Scalbert A; Weiderpass E; Christakoudi S; Gunter MJ; Jenab M
Int J Cancer; 2022 Apr; 150(8):1255-1268. PubMed ID: 34843121
[TBL] [Abstract][Full Text] [Related]
38. The '
Ridlon JM; Devendran S; Alves JM; Doden H; Wolf PG; Pereira GV; Ly L; Volland A; Takei H; Nittono H; Murai T; Kurosawa T; Chlipala GE; Green SJ; Hernandez AG; Fields CJ; Wright CL; Kakiyama G; Cann I; Kashyap P; McCracken V; Gaskins HR
Gut Microbes; 2020 May; 11(3):381-404. PubMed ID: 31177942
[TBL] [Abstract][Full Text] [Related]
39. Protective effect of agaro-oligosaccharides on gut dysbiosis and colon tumorigenesis in high-fat diet-fed mice.
Higashimura Y; Naito Y; Takagi T; Uchiyama K; Mizushima K; Ushiroda C; Ohnogi H; Kudo Y; Yasui M; Inui S; Hisada T; Honda A; Matsuzaki Y; Yoshikawa T
Am J Physiol Gastrointest Liver Physiol; 2016 Mar; 310(6):G367-75. PubMed ID: 26767984
[TBL] [Abstract][Full Text] [Related]
40. Functional changes of the gastric bypass microbiota reactivate thermogenic adipose tissue and systemic glucose control via intestinal FXR-TGR5 crosstalk in diet-induced obesity.
Münzker J; Haase N; Till A; Sucher R; Haange SB; Nemetschke L; Gnad T; Jäger E; Chen J; Riede SJ; Chakaroun R; Massier L; Kovacs P; Ost M; Rolle-Kampczyk U; Jehmlich N; Weiner J; Heiker JT; Klöting N; Seeger G; Morawski M; Keitel V; Pfeifer A; von Bergen M; Heeren J; Krügel U; Fenske WK
Microbiome; 2022 Jun; 10(1):96. PubMed ID: 35739571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
